| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCNN1B GJC1 SLC37A1 ATP5MF SERINC5 SLC35F1 TMEM241 ABCA5 PSG3 KCNK9 ABCB5 KCNK15 SLC35B1 | 2.14e-06 | 1180 | 47 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SCNN1B GJC1 SLC37A1 ATP5MF SERINC5 SLC35F1 TMEM241 ABCA5 PSG3 KCNK9 ABCB5 KCNK15 SLC35B1 | 5.67e-06 | 1289 | 47 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | apyrase activity | 1.62e-05 | 3 | 47 | 2 | GO:0004050 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.93e-04 | 9 | 47 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 2.41e-04 | 10 | 47 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 2.94e-04 | 11 | 47 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 3.53e-04 | 12 | 47 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 3.62e-04 | 59 | 47 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 4.85e-04 | 14 | 47 | 2 | GO:0005338 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 4.96e-04 | 431 | 47 | 6 | GO:0004984 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 6.09e-04 | 293 | 47 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 6.37e-04 | 16 | 47 | 2 | GO:0022841 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 9.04e-04 | 19 | 47 | 2 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 9.04e-04 | 19 | 47 | 2 | GO:0022840 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 9.68e-04 | 884 | 47 | 8 | GO:0004930 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 1.00e-03 | 20 | 47 | 2 | GO:0017110 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.57e-03 | 25 | 47 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 1.57e-03 | 25 | 47 | 2 | GO:0003707 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 1.83e-03 | 27 | 47 | 2 | GO:0015271 | |
| GeneOntologyMolecularFunction | complement binding | 2.57e-03 | 32 | 47 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 3.80e-03 | 39 | 47 | 2 | GO:0015605 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.19e-03 | 138 | 47 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.35e-03 | 459 | 47 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 5.12e-03 | 477 | 47 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 5.94e-03 | 49 | 47 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | channel activity | 7.62e-03 | 525 | 47 | 5 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.68e-03 | 526 | 47 | 5 | GO:0022803 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 8.52e-03 | 59 | 47 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.54e-03 | 343 | 47 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 8.73e-03 | 180 | 47 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 8.80e-03 | 60 | 47 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 9.08e-03 | 61 | 47 | 2 | GO:0098531 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 9.69e-03 | 187 | 47 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.18e-02 | 201 | 47 | 3 | GO:0061135 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 2.11e-05 | 547 | 45 | 8 | GO:0007606 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 1.29e-04 | 524 | 45 | 7 | GO:0009593 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 1.29e-04 | 8 | 45 | 2 | GO:2000427 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 1.48e-04 | 722 | 45 | 8 | GO:0051606 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 2.07e-04 | 10 | 45 | 2 | GO:2000425 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide-sugar transmembrane transport | 3.03e-04 | 12 | 45 | 2 | GO:0090481 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 3.33e-04 | 432 | 45 | 6 | GO:0050911 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar transmembrane transport | 3.58e-04 | 13 | 45 | 2 | GO:0015780 | |
| GeneOntologyBiologicalProcess | cholesterol metabolic process | 4.35e-04 | 163 | 45 | 4 | GO:0008203 | |
| GeneOntologyBiologicalProcess | sensory perception | VN1R3 SCNN1B GJC1 OR10G9 OR10G8 OR10G2 OR10G7 OR10G4 OR10D4P | 4.36e-04 | 1072 | 45 | 9 | GO:0007600 |
| GeneOntologyBiologicalProcess | lipid droplet formation | 4.80e-04 | 15 | 45 | 2 | GO:0140042 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 4.91e-04 | 465 | 45 | 6 | GO:0007608 | |
| GeneOntologyBiologicalProcess | secondary alcohol metabolic process | 5.81e-04 | 176 | 45 | 4 | GO:1902652 | |
| GeneOntologyBiologicalProcess | sterol metabolic process | 5.93e-04 | 177 | 45 | 4 | GO:0016125 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 6.13e-04 | 485 | 45 | 6 | GO:0050907 | |
| GeneOntologyBiologicalProcess | stabilization of membrane potential | 6.20e-04 | 17 | 45 | 2 | GO:0030322 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.37e-04 | 8 | 47 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.76e-04 | 9 | 47 | 2 | GO:0044217 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.43e-05 | 28 | 32 | 3 | MP:0020950 | |
| Domain | Anaphylatoxin_comp_syst | 5.65e-05 | 5 | 45 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 5.65e-05 | 5 | 45 | 2 | IPR001840 | |
| Domain | ANATO | 1.18e-04 | 7 | 45 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.18e-04 | 7 | 45 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.18e-04 | 7 | 45 | 2 | PS01177 | |
| Domain | ANATO | 1.18e-04 | 7 | 45 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.18e-04 | 7 | 45 | 2 | IPR000020 | |
| Domain | GDA1_CD39 | 1.57e-04 | 8 | 45 | 2 | PF01150 | |
| Domain | MacrogloblnA2_CS | 1.57e-04 | 8 | 45 | 2 | IPR019742 | |
| Domain | GDA1_CD39_NTPASE | 1.57e-04 | 8 | 45 | 2 | PS01238 | |
| Domain | GDA1_CD39_NTPase | 1.57e-04 | 8 | 45 | 2 | IPR000407 | |
| Domain | Thiol-ester_cl | 1.57e-04 | 8 | 45 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.57e-04 | 8 | 45 | 2 | IPR019565 | |
| Domain | 2pore_dom_K_chnl_TASK | 2.02e-04 | 9 | 45 | 2 | IPR003092 | |
| Domain | A2M_N | 2.52e-04 | 10 | 45 | 2 | PF01835 | |
| Domain | A2M_N_2 | 2.52e-04 | 10 | 45 | 2 | PF07703 | |
| Domain | A2M_N | 2.52e-04 | 10 | 45 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.52e-04 | 10 | 45 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.52e-04 | 10 | 45 | 2 | PS00477 | |
| Domain | A2M_recep | 2.52e-04 | 10 | 45 | 2 | PF07677 | |
| Domain | A2M_comp | 2.52e-04 | 10 | 45 | 2 | PF07678 | |
| Domain | A2M | 2.52e-04 | 10 | 45 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.52e-04 | 10 | 45 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.52e-04 | 10 | 45 | 2 | IPR011626 | |
| Domain | Macroglobln_a2 | 2.52e-04 | 10 | 45 | 2 | IPR001599 | |
| Domain | AdipoR/HlyIII-related | 3.08e-04 | 11 | 45 | 2 | IPR004254 | |
| Domain | HlyIII | 3.08e-04 | 11 | 45 | 2 | PF03006 | |
| Domain | 2pore_dom_K_chnl | 5.84e-04 | 15 | 45 | 2 | IPR003280 | |
| Domain | C345C | 7.54e-04 | 17 | 45 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 8.47e-04 | 18 | 45 | 2 | IPR008930 | |
| Domain | NTR | 9.46e-04 | 19 | 45 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 9.46e-04 | 19 | 45 | 2 | IPR018933 | |
| Domain | K_chnl_dom | 1.16e-03 | 21 | 45 | 2 | IPR013099 | |
| Domain | Ion_trans_2 | 1.16e-03 | 21 | 45 | 2 | PF07885 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.17e-03 | 685 | 45 | 7 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.23e-03 | 691 | 45 | 7 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.24e-03 | 692 | 45 | 7 | IPR000276 | |
| Domain | Netrin_domain | 1.39e-03 | 23 | 45 | 2 | IPR001134 | |
| Domain | NTR | 1.39e-03 | 23 | 45 | 2 | PS50189 | |
| Domain | TIMP-like_OB-fold | 1.78e-03 | 26 | 45 | 2 | IPR008993 | |
| Domain | Olfact_rcpt | 2.46e-03 | 393 | 45 | 5 | IPR000725 | |
| Domain | ABC_transporter_CS | 4.60e-03 | 42 | 45 | 2 | IPR017871 | |
| Domain | GPCR_Rhodpsn_7TM | 5.16e-03 | 670 | 45 | 6 | IPR017452 | |
| Domain | 7tm_1 | 5.42e-03 | 677 | 45 | 6 | PF00001 | |
| Domain | ABC_TRANSPORTER_2 | 5.97e-03 | 48 | 45 | 2 | PS50893 | |
| Domain | ABC_tran | 5.97e-03 | 48 | 45 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 6.21e-03 | 49 | 45 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 6.46e-03 | 50 | 45 | 2 | IPR003439 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 2.91e-05 | 70 | 36 | 4 | MM14984 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.13e-04 | 190 | 36 | 5 | MM15687 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.32e-04 | 7 | 36 | 2 | MM14685 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.76e-04 | 8 | 36 | 2 | M27737 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.76e-04 | 8 | 36 | 2 | M47872 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.76e-04 | 8 | 36 | 2 | MM15486 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 1.76e-04 | 8 | 36 | 2 | M27031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 2.26e-04 | 9 | 36 | 2 | M47802 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 3.44e-04 | 11 | 36 | 2 | M47874 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 3.44e-04 | 11 | 36 | 2 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 4.12e-04 | 12 | 36 | 2 | MM1368 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS | 4.86e-04 | 13 | 36 | 2 | M47945 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 4.86e-04 | 13 | 36 | 2 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 6.52e-04 | 15 | 36 | 2 | M7146 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS | 6.52e-04 | 15 | 36 | 2 | MM15921 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY | 6.52e-04 | 15 | 36 | 2 | M39608 | |
| Pathway | KEGG_STEROID_BIOSYNTHESIS | 8.42e-04 | 17 | 36 | 2 | M5872 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 8.42e-04 | 17 | 36 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 8.42e-04 | 17 | 36 | 2 | MM1369 | |
| Pathway | WP_CHOLESTEROL_SYNTHESIS_DISORDERS | 9.46e-04 | 18 | 36 | 2 | M45528 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 1.06e-03 | 19 | 36 | 2 | M27452 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 1.06e-03 | 19 | 36 | 2 | MM15194 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 1.17e-03 | 20 | 36 | 2 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 1.42e-03 | 22 | 36 | 2 | M39502 | |
| Pathway | REACTOME_CHOLESTEROL_BIOSYNTHESIS | 2.14e-03 | 27 | 36 | 2 | MM14735 | |
| Pathway | REACTOME_CHOLESTEROL_BIOSYNTHESIS | 2.14e-03 | 27 | 36 | 2 | M16227 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 2.91e-03 | 389 | 36 | 5 | M14091 | |
| Pathway | REACTOME_NUCLEOTIDE_CATABOLISM | 3.58e-03 | 35 | 36 | 2 | MM15550 | |
| Pathway | REACTOME_NUCLEOTIDE_CATABOLISM | 3.58e-03 | 35 | 36 | 2 | M27829 | |
| Pathway | WP_ENTEROCYTE_CHOLESTEROL_METABOLISM | 3.78e-03 | 36 | 36 | 2 | M48067 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.91e-03 | 417 | 36 | 5 | M4072 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 5.04e-03 | 636 | 36 | 6 | M41834 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 5.12e-03 | 42 | 36 | 2 | M27172 | |
| Pathway | WP_OXIDATIVE_DAMAGE_RESPONSE | 5.12e-03 | 42 | 36 | 2 | MM15945 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 5.61e-03 | 44 | 36 | 2 | M11911 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 6.38e-03 | 47 | 36 | 2 | M39853 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 7.76e-03 | 52 | 36 | 2 | MM15920 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 8.35e-03 | 54 | 36 | 2 | MM14655 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 8.65e-03 | 55 | 36 | 2 | M27001 | |
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 1.79e-06 | 2 | 47 | 2 | 3944109 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.79e-06 | 2 | 47 | 2 | 16565498 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15998580 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.79e-06 | 2 | 47 | 2 | 25339671 | |
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.79e-06 | 2 | 47 | 2 | 15390104 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17728371 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24269738 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.79e-06 | 2 | 47 | 2 | 3037333 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.79e-06 | 2 | 47 | 2 | 7373044 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 11726230 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19062096 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 4216347 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.79e-06 | 2 | 47 | 2 | 3696167 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6149580 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6149581 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.79e-06 | 2 | 47 | 2 | 17921792 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21880985 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.79e-06 | 2 | 47 | 2 | 1699796 | |
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.79e-06 | 2 | 47 | 2 | 6978711 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.79e-06 | 2 | 47 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.79e-06 | 2 | 47 | 2 | 2997024 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.79e-06 | 2 | 47 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.79e-06 | 2 | 47 | 2 | 16098595 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 35898513 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 33353966 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 3008092 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.79e-06 | 2 | 47 | 2 | 19933335 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12115608 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 3542363 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.79e-06 | 2 | 47 | 2 | 3624865 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28873507 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.79e-06 | 2 | 47 | 2 | 8428773 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2387317 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 8132550 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21857912 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.79e-06 | 2 | 47 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.79e-06 | 2 | 47 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.79e-06 | 2 | 47 | 2 | 15787745 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6609966 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12207352 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 1.79e-06 | 2 | 47 | 2 | 2900855 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24638111 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.79e-06 | 2 | 47 | 2 | 4514997 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2395880 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28404855 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26814708 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 276882 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.79e-06 | 2 | 47 | 2 | 21345967 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6192448 | ||
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.79e-06 | 2 | 47 | 2 | 5919331 | |
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 1.79e-06 | 2 | 47 | 2 | 6832377 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6167582 | ||
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.79e-06 | 2 | 47 | 2 | 3167981 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16908004 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30026462 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12606724 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 1.79e-06 | 2 | 47 | 2 | 1438267 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7365238 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 3794341 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6559257 | ||
| Pubmed | Complement and c4 null alleles in severe chronic adult periodontitis. | 1.79e-06 | 2 | 47 | 2 | 17257223 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2272665 | ||
| Pubmed | Multiple C4/Slp genes distinguished by expression after transfection. | 1.79e-06 | 2 | 47 | 2 | 3023818 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7545960 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.79e-06 | 2 | 47 | 2 | 27758680 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19150565 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7391573 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17506029 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22387014 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17971360 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.79e-06 | 2 | 47 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.79e-06 | 2 | 47 | 2 | 20506482 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23715124 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 30041577 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 3464002 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2993295 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2572548 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22785613 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2302180 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.79e-06 | 2 | 47 | 2 | 29928053 | |
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.79e-06 | 2 | 47 | 2 | 3862104 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.79e-06 | 2 | 47 | 2 | 17971229 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.79e-06 | 2 | 47 | 2 | 34358307 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12480675 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 32691186 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 11749039 | ||
| Pubmed | Genetic deficiency in complement component 4b does not alter radiation-induced lung disease in mice. | 1.79e-06 | 2 | 47 | 2 | 23259761 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.79e-06 | 2 | 47 | 2 | 18360261 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 6881182 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22151770 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26800705 | ||
| Pubmed | KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1. | 1.79e-06 | 2 | 47 | 2 | 11431495 | |
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.79e-06 | 2 | 47 | 2 | 18091514 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29080553 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.79e-06 | 2 | 47 | 2 | 23749435 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 11168010 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23918728 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 1.57e-06 | 191 | 47 | 5 | chr11q24 | |
| Cytoband | 11q24.2 | 3.82e-05 | 63 | 47 | 3 | 11q24.2 | |
| Cytoband | 11q24.1 | 6.68e-04 | 37 | 47 | 2 | 11q24.1 | |
| Cytoband | 20q13.12 | 1.75e-03 | 60 | 47 | 2 | 20q13.12 | |
| GeneFamily | Olfactory receptors, family 10 | 3.35e-09 | 66 | 36 | 6 | 157 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.38e-04 | 9 | 36 | 2 | 1234 | |
| GeneFamily | Progestin and adipoQ receptor family | 2.10e-04 | 11 | 36 | 2 | 930 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 3.98e-04 | 15 | 36 | 2 | 277 | |
| GeneFamily | Complement system|Sushi domain containing | 2.33e-03 | 36 | 36 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 2.46e-03 | 37 | 36 | 2 | 454 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.66e-06 | 198 | 45 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 158 | 45 | 4 | 5590fd7d7833685abd9bb86ef704c7f879b3ddbd | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.37e-05 | 166 | 45 | 4 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 2.37e-05 | 166 | 45 | 4 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-05 | 177 | 45 | 4 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.18e-05 | 179 | 45 | 4 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 181 | 45 | 4 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 181 | 45 | 4 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 181 | 45 | 4 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 182 | 45 | 4 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-05 | 182 | 45 | 4 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.61e-05 | 185 | 45 | 4 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 189 | 45 | 4 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.01e-05 | 190 | 45 | 4 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-05 | 196 | 45 | 4 | 88dc4e3efd7ea07617ecde142ec47cc57608f81b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-05 | 199 | 45 | 4 | e751eb67510f8a5842dcfed44134160919cdb713 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-05 | 199 | 45 | 4 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-05 | 200 | 45 | 4 | ce0c259f7fa4c0aa6d00e0bb362c029e96fce19e | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 4.89e-05 | 200 | 45 | 4 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-05 | 200 | 45 | 4 | 156a949b3b59fb2b00e4f4a8933169f247a5f660 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.06e-04 | 130 | 45 | 3 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-04 | 132 | 45 | 3 | c6bf0b4b9e33b517629faf4559a21d7ba720ee6a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-04 | 142 | 45 | 3 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.93e-04 | 153 | 45 | 3 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 154 | 45 | 3 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-04 | 154 | 45 | 3 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 154 | 45 | 3 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-04 | 154 | 45 | 3 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-04 | 156 | 45 | 3 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.31e-04 | 157 | 45 | 3 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-04 | 157 | 45 | 3 | 10989c7046fc859f137c7cef3296508d4476f11f | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 5.41e-04 | 158 | 45 | 3 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.72e-04 | 161 | 45 | 3 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.82e-04 | 162 | 45 | 3 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-04 | 165 | 45 | 3 | baff639a7046fb5cacb70f341b6d24cef3519f8e | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-04 | 165 | 45 | 3 | 6fdce8b23736409a23884ef3918638ffc067a86f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 165 | 45 | 3 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-04 | 165 | 45 | 3 | 60b500eb2c10cccf309b8fb28a9119da22d6889c | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-04 | 165 | 45 | 3 | dd4d36ff8efb89fee1fb4c48d1b8f46902119909 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 165 | 45 | 3 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-04 | 166 | 45 | 3 | 94a00edf66d54bc5f7343daea700ca26cf38fd90 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.36e-04 | 167 | 45 | 3 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-04 | 167 | 45 | 3 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-04 | 168 | 45 | 3 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-04 | 168 | 45 | 3 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo|GI_small-bowel / Manually curated celltypes from each tissue | 6.92e-04 | 172 | 45 | 3 | 3df11aefc09762fd1f94441324551178e030b249 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.28e-04 | 175 | 45 | 3 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.40e-04 | 176 | 45 | 3 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-04 | 176 | 45 | 3 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-04 | 177 | 45 | 3 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-04 | 177 | 45 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-04 | 177 | 45 | 3 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-04 | 177 | 45 | 3 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 179 | 45 | 3 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 7.90e-04 | 180 | 45 | 3 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.90e-04 | 180 | 45 | 3 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.02e-04 | 181 | 45 | 3 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-04 | 183 | 45 | 3 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.28e-04 | 183 | 45 | 3 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.28e-04 | 183 | 45 | 3 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 8.28e-04 | 183 | 45 | 3 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-04 | 183 | 45 | 3 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-04 | 184 | 45 | 3 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.42e-04 | 184 | 45 | 3 | 7aa245b73e10fd73d292e822de6b72920aa12355 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-04 | 184 | 45 | 3 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.42e-04 | 184 | 45 | 3 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.42e-04 | 184 | 45 | 3 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-04 | 184 | 45 | 3 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-04 | 184 | 45 | 3 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-04 | 185 | 45 | 3 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-04 | 185 | 45 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.55e-04 | 185 | 45 | 3 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.55e-04 | 185 | 45 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.55e-04 | 185 | 45 | 3 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 8.55e-04 | 185 | 45 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 185 | 45 | 3 | 11fbea1eb1d9a3e4480d0d2b0f7b02e2866b8142 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-04 | 185 | 45 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-04 | 185 | 45 | 3 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-04 | 185 | 45 | 3 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 8.55e-04 | 185 | 45 | 3 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.55e-04 | 185 | 45 | 3 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-04 | 186 | 45 | 3 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 8.68e-04 | 186 | 45 | 3 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.68e-04 | 186 | 45 | 3 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-04 | 186 | 45 | 3 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.68e-04 | 186 | 45 | 3 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.68e-04 | 186 | 45 | 3 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 8.68e-04 | 186 | 45 | 3 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-04 | 186 | 45 | 3 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 187 | 45 | 3 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 187 | 45 | 3 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.82e-04 | 187 | 45 | 3 | c80e03d5aa498b4eecbc46565fabf9b5be10c71c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.82e-04 | 187 | 45 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-04 | 187 | 45 | 3 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.82e-04 | 187 | 45 | 3 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-04 | 187 | 45 | 3 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-04 | 187 | 45 | 3 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-04 | 187 | 45 | 3 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| Drug | 2-aminothiophenol | 1.09e-05 | 3 | 44 | 2 | ctd:C005464 | |
| Drug | phellamurin | 2.18e-05 | 4 | 44 | 2 | CID000193876 | |
| Drug | cathenamine | 2.18e-05 | 4 | 44 | 2 | CID000443361 | |
| Drug | 5-dehydroepisterol | 3.64e-05 | 5 | 44 | 2 | CID010894570 | |
| Disease | Complement deficiency disease | 9.21e-04 | 33 | 40 | 2 | C0272242 | |
| Disease | Graves' disease (is_implicated_in) | 1.29e-03 | 39 | 40 | 2 | DOID:12361 (is_implicated_in) | |
| Disease | reading | 1.56e-03 | 43 | 40 | 2 | EFO_0005229 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.56e-03 | 43 | 40 | 2 | DOID:9074 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 2.18e-03 | 190 | 40 | 3 | C0020538 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 3.22e-03 | 62 | 40 | 2 | DOID:9074 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.97e-03 | 69 | 40 | 2 | DOID:4450 (is_implicated_in) | |
| Disease | Lupus Erythematosus, Systemic | 4.20e-03 | 71 | 40 | 2 | C0024141 | |
| Disease | Lung diseases | 5.04e-03 | 78 | 40 | 2 | C0024115 | |
| Disease | hypertrophic cardiomyopathy | 6.94e-03 | 92 | 40 | 2 | EFO_0000538 | |
| Disease | neurotic disorder | 8.31e-03 | 101 | 40 | 2 | EFO_0004257 | |
| Disease | QRS-T angle | 9.12e-03 | 106 | 40 | 2 | EFO_0020097 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FHYGLYFYTVKFLAV | 1091 | Q8WWZ7 | |
| FHQFYCYLVYEFDKF | 241 | Q8IZ81 | |
| YFAYRLYSAIHDFGF | 251 | Q9UJ72 | |
| HLAPSFYFVAFYYHG | 536 | P0C0L5 | |
| CYAFSHAFIYFAYAA | 921 | Q2M3G0 | |
| YFLLCVNYFFYGETV | 131 | O95674 | |
| YCFSANYIYHLFVNG | 421 | O75355 | |
| FFHAYYYCFITLTTI | 186 | Q9NPC2 | |
| YFFHFLGSTECFLYT | 101 | Q8NGN6 | |
| SYAGCVSQLFFYHFL | 91 | Q8NGN7 | |
| YFFHFLGSTECFLYT | 101 | Q8NGN3 | |
| VAVYQFGSALAHFYY | 146 | Q86WK9 | |
| GHFYTQDCYVFLCRY | 926 | Q13045 | |
| FEGWTFFHAYYYCFI | 181 | Q9H427 | |
| FFHAYYYCFITLTTI | 186 | Q9H427 | |
| RGQFYAFSNFYYTFH | 346 | Q5MY95 | |
| FCLFSVFISAYYLYG | 26 | P52848 | |
| YFFHFLGGTECFLYR | 101 | Q8NGN5 | |
| TNTAYCFSFFYHMYG | 831 | Q7Z553 | |
| VSVYQYGSALAHFFY | 151 | Q8TEZ7 | |
| LGYFYNIHSFGFYVV | 146 | P57057 | |
| ACYVLFSYSFSYKHL | 71 | P56134 | |
| YCYVPGLYFFSLNVH | 186 | Q9BXJ1 | |
| LCGYFAFYHALYPRA | 221 | Q9HCG7 | |
| YFLYGFQVHPFYVCS | 196 | P36383 | |
| GHFFAVAIYAVYFCF | 521 | Q14534 | |
| FFAHFYPYTYTDLQC | 391 | Q5U5Z8 | |
| GHCYAEFFYNWYFLI | 186 | Q9Y5N1 | |
| FTSIFYPHYGNCYIF | 261 | P51168 | |
| YCLFSLYAAYHVFFG | 16 | Q9Y2B1 | |
| HLAPSFYFVAFYYHG | 536 | P0C0L4 | |
| YFFHFLGSTECFLYT | 101 | Q8NGN4 | |
| LYFFHFLGSTQCFLY | 106 | Q8NGC3 | |
| FTYYHSGENLYLSCF | 341 | Q16557 | |
| LCFLGVFVCYFYYGI | 16 | P78383 | |
| AIDAGYRHFDCAYFY | 26 | Q96JD6 | |
| PTFFYAGYSYLICDH | 246 | Q53H76 | |
| LYSLFCGLFLFHYKF | 321 | Q5T1Q4 | |
| FLYYADHFKLYSGFC | 1191 | Q8IVF5 | |
| CSFHPSYDFYRYNFS | 466 | Q9Y458 | |
| NFGSCYEVHFRYFYN | 46 | Q6UDR6 | |
| TVYIYSYFHFVFFLA | 386 | Q86VE9 | |
| CVGHYNHRYFFSFCF | 191 | Q969W1 | |
| FLYFYRFHGSCCASG | 211 | Q24JQ0 | |
| SGFTAVYFLIYAVHY | 596 | Q99805 | |
| YFFCATLSYYFVFDH | 46 | O75845 | |
| LGNFFLLYHYSFLCF | 21 | Q9BXE9 | |
| GLYLLASAAAFYYVF | 46 | Q8N6I4 | |
| ICYYGKHYSTFFFQT | 296 | Q70EL1 |